Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 12 (5-6) , 277-283
Abstract
Background: Hyperuricemia can be the consequence of an increased urate production, a decreased renal excretion, or both. An increased prevalence of hyperuricemia has been described in essential hypertensive patients partly due to a decreased renal urinary urate excretion (UUE). Hyperuricemia has been shown to be associated with an increased risk of cardiovascular disease in hypertensive patients in some but not in all epidemiological studies in which this relationship has been investigated. Objective: To assess the influence of low UUE in the association between serum urate, renal function and hypertension severity. Patients and Methods: This cross‐sectional study was carried out in a sample of 677 male hypertensive patients, aged 35–60 years, with essential arterial hypertension consecutively attended in a hospital hypertension unit. The presence of hypertension‐related organ damage at diagnosis was classified according to classical WHO criteria as grade 1, 2 or 3. Urate underexcretion was defined as 24‐h urinary urate below the product serum urate × 100. Results: Mean serum urate levels were 6.4 ± 1.6 mg/dl in the total sample. Hyperuricemia (serum urate >7 mg/dl) was present in 28.5% of patients and only 17.0% had underexcretory hyperuricemia. This subgroup of patients exhibited the higher rate of hypertension‐related target organ damage (TOD). A multivariate analysis, showed that underexcretory hyperuricemia but not hyperuricemia remained an independent predictor of TOD (odds ratio 2.5. 95% CI 1.6–3.89). Serum urate correlated positively with serum creatinine in hyperuricemic patients (r = 0.50, p < 0.001), but not in patients with underexcretory hyperuricemia (r = 0.21, p = 0.18). Conclusions: Underexcretory hyper‐uricemia is strongly related to hypertensive organ damage and this relationship does not seem to be mediated by a decreased renal function. This aspect could underline the predictive value of hyperuricemia independently of serum creatinine. UUE could improve the clinical predictive value of hyperuricemia as a cardiovascular risk factor.Keywords
This publication has 14 references indexed in Scilit:
- Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agentAmerican Journal of Hypertension, 2002
- Molecular identification of a renal urate–anion exchanger that regulates blood urate levelsNature, 2002
- Uric acid and cardiovascular riskCurrent Opinion in Pharmacology, 2002
- Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive HypertensionNew England Journal of Medicine, 2002
- Relations of Hyperuricemia with the Various Components of the Insulin Resistance Syndrome in Young Black and White Adults: The CARDIA StudyAnnals of Epidemiology, 1998
- Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?Hypertension, 1994
- Evaluation of Renal Handling of Uric Acid in Essential Hypertension: Hyperuricemia Related to Decreased Urate SecretionNephron, 1991
- Renal handling of uric acid in gout: Impaired tubular transport of urate not dependent on serum urate levelsMetabolism, 1986
- Renal Handling of Uric Acid in Normal Subjects by Means of the Pyrazinamide and Probenecid TestsNephron, 1983
- HYPERTENSION AND HYPERURICÆMIAThe Lancet, 1966